DKFZ Immunology, Infection and Cancer

@dkfz-iic.bsky.social

The 'Immunology, Infection and Cancer' research program at the DKFZ in Heidelberg focuses on the interactions between pathogens and the immune system and how they drive carcinogenesis with the aim to develop novel immunotherapeutic approaches to cancer.

📣 i2 Seminar on Wednesday, 9th July at 16:00 in K1/K2! Talks will be given by Ann-Katrin Schlosser (AG Riemer) & Miray Cetin (AG Hartmann) who will focus on the anti-tumor efficacy of multi-epitope therapeutic HPV vaccine, as well as modulation of breast TME along a macrophage axis!@dkfz.bsky.social

Bild

Today, we will focus on non-cancer-cell-autonomous immunity by learning about reprogramming CAFs and optimising CAR-T cells, with the aim of promoting anti-tumour immunity. Join us at 4 pm in ATV, where talks will be given by Dr. Micaela Domingues (AG Munir) and Vincenz Buschinger (AG Buchholz)!

Bild

Join us today in the main building at 4 pm for talks given by David Vonhören and Dr. Katia Dittus who will tell us about intratumoral NK and T cell interactions in brain tumors and RadioVirotherapy for the treatment of refractory tumors. Looking forward to the exciting talks and snacks afterwards!✌🏼

Bild

From space tech to pandemic science! We're excited to have been hosting the Autonomous Intelligent Mobile Manipulator (AIMM) robot (picture below) and colleagues from the DLR Robotics Institute as part of the Helmholtz CoViPa project, bringing together immunology, virology and robotics! 🤖 🦠 🧬

Bild

Researchers at the DKFZ and the Heidelberg University Hospital have discovered that the Epstein-Barr virus increases the ability of infected immune cells to migrate. In this way, the pathogen promotes its spread in the body - a potential approach for new therapies. t1p.de/g626g

How the Epstein-Barr virus promotes its spread in the body

Many people are infected with the Epstein-Barr virus (EBV), and most are unaware of it. However, EBV can sometimes cause cancer, and this pathogen also appears to play an important role in multiple sc...

t1p.de

Congratulations! 🎉 Michael Platten was nominated as ambassador in Germany for the ERC network! The newly selected ambassadors are part of an initiative to promote frontier research. Great news for science in Europe! @michael-platten.bsky.social @platten-lab.bsky.social @ercgrantees.bsky.social

Deutsches Krebsforschungszentrum (DKFZ)@dkfz.bsky.social · last yr.

@michael-platten.bsky.social has been selected and nominated as Ambassador for the ERC network. The @erc.europa.eu & the @ercgrantees.bsky.social launched the new Ambassadors on 28 April. This joint initiative aims to promote investment in frontier research and highlight the importance of #research.

Photo: Jung/DKFZ

🧬 New Paper out! Kathrin Wellach and Angelika Riemer from our department published a new highly sensitive cytotoxicity assay using live-cell imaging. With this method, epitope-specific T cells can be functionally analyzed for their cytotoxic capacity! 📄 Check it out: tinyurl.com/cytotoxicity...

Frontiers | Highly sensitive live-cell imaging-based cytotoxicity assay enables functional validation of rare epitope-specific CTLs

Many immunotherapeutic approaches aim to induce epitope-specific T-cell cytotoxicity. However, the identification—and especially the functional validation—of...

tinyurl.com